Protokinetix Inc (PKTX) 0.0600 $PKTX ProtoKinetix'

New Post Public Reply Private Reply Replies (0) Message Board

Aug 30, 2016 at 1:17 PM

Protokinetix Inc (PKTX) 0.0600 $PKTX

ProtoKinetix' AAGP(TM) has been Published in the Journal of Tissue Engineering and Regenerative Medicine
BusinessWire - Tue Jun 07, 10:00AM CDT
ProtoKinetix, Incorporated (OTCQB

KTX) (the "Company" or "ProtoKinetix"

(www.protokinetix.com) is pleased to announce that a paper submitted by Dr. Kevin Gregory-Evans on ProtoKinetix' AAGP(TM) has been published in the Journal of Tissue Engineering and Regenerative Medicine and is available online at:

ProtoKinetix Updates Progress Toward Clinical Trial Application for AAGP(TM)
BusinessWire - Thu May 12, 9:00AM CDT
ProtoKinetix, Incorporated (OTCQB: PKTX) (the "Company" or "ProtoKinetix"

(www.protokinetix.com) is pleased to update its stockholders on the progress that it has made toward the application to conduct clinical trials in Canada with Health Canada.

AAGP(TM) Improves Results in Stem Cells Transplanted in Retina Tissue by 300%
BusinessWire - Mon May 02, 9:41AM CDT
ProtoKinetix, Incorporated (OTCQB

KTX) (the "Company" or "ProtoKinetix"

(www.protokinetix.com) is pleased to announce that a paper submitted by Dr. Kevin Gregory-Evans on ProtoKinetix' AAGP(TM) has been accepted by the Journal of Tissue Engineering and Regenerative Medicine for publication. The date of publication is unknown at this time but should be available online in advance of the printed version. AAGP(TM), an antifreeze glycopeptide, has been demonstrated to significantly improve the viable yield of stem cells transplanted in retinal tissue at the University of British Columbia under the guidance of Dr. Kevin Gregory-Evans.

ProtoKinetix Outlines Steps to Clinical Trial Application for AAGP(TM)
BusinessWire - Tue Apr 26, 8:00AM CDT
ProtoKinetix, Incorporated (OTCQB: PKTX) (the "Company" or "ProtoKinetix"

(www.protokinetix.com) outlines the steps to be completed for the application to conduct a clinical trial in Canada.

ProtoKinetix Corporate Update
BusinessWire - Tue Jan 05, 2:24PM CST
ProtoKinetix, Incorporated (OTCQB

KTX) (the "Company" or "ProtoKinetix"

(www.protokinetix.com) is pleased to provide the following corporate update to its stockholders:

AAGP(TM) Found to Significantly Improve Islet Cell Transplantation in Type 1 Diabetes Patients
BusinessWire - Thu Dec 17, 12:30PM CST
ProtoKinetix, Incorporated (OTCQB

KTX) (the "Company" or "ProtoKinetix"

(www.protokinetix.com) is pleased to announce that their molecule, AAGP(TM), an antifreeze glycopeptide that mimics a naturally occurring glycoprotein found in Arctic fish is helping to significantly improve the efficacy of Cell Transplant Treatments for diabetes - a procedure that transplants insulin producing islet to render them insulin independent for periods of time.

ProtoKinetix Completes Private Placement
BusinessWire - Mon Nov 09, 8:25AM CST
ProtoKinetix, Incorporated (OTCQB: PKTX) (the "Company" or "ProtoKinetix"

(www.protokinetix.com) is pleased to announce that it has completed a non-brokered private placement (the "Offering"

that closed on November 6, 2015. A total of $200,000 was raised with the offering of 5,000,000 units purchased. Each unit is equivalent to one share of common stock of the Company at $0.04 per share and a non-detachable warrant for one share of common stock of the Company exercisable, on or before December 28, 2015, at $0.04 per share.

ProtoKinetix Begins Testing Diabetic Mice with AAGP(TM) at the University of Alberta
BusinessWire - Fri Sep 18, 9:00AM CDT
ProtoKinetix, Incorporated (OTC: PKTX) (the "Company" or "ProtoKinetix"

(www.protokinetix.com) is pleased to announce that it has begun testing NOD (Non Obese Diabetic) mice with its AAGP(TM) molecule at the James Shapiro laboratory at the University of Alberta.

ProtoKinetix' AAGP(TM) to Be Presented at the Congress of the International Pancreas and Islet Transplant Association
BusinessWire - Thu Sep 10, 8:00AM CDT
ProtoKinetix, Incorporated (OTC: PKTX) (the "Company" or "ProtoKinetix"

(www.protokinetix.com) is pleased to announce that AAGP(TM) will be presented at the 2015 Joint Congress of the IPITA-IXA-CTS on Monday, November 16, 2015. The Joint Congress of the International Pancreas and Islet Transplant Association (IPITA), the International Xenotransplantation Association (IXA) and the Cell Transplant Society (CTS) to be held in Melbourne, Australia, 15-19 November 2015.

ProtoKinetix Reports on Its Strong Collaboration with the James Shapiro Laboratory at the University of Alberta
BusinessWire - Tue Aug 04, 8:15AM CDT
ProtoKinetix, Incorporated (OTC: PKTX) (the "Company" or "ProtoKinetix"

(www.protokinetix.com) is pleased to report on its collaboration with the James Shapiro laboratory at the University of Alberta. The sole intention of the collaboration is to develop a commercial product pipeline of therapeutic applications for the AAGP(TM) family of molecules.

ProtoKinetix Announces Appointment of New Director and Provides Corporate Update
BusinessWire - Wed Jul 01, 6:17PM CDT
ProtoKinetix, Incorporated (OTC: PKTX) (the "Company" or "ProtoKinetix"

(www.protokinetix.com) is pleased to announce that Edward P. McDonough was appointed to the company's board of directors. The Company has issued a two-year option for 1,000,000 shares of common stock subject to vesting exercisable at $0.10 per share to Mr. McDonough in connection with his appointment to the Board and for services to the Company.

ProtoKinetix Upgrades to OTCQB
PR Newswire - Mon Jun 08, 8:25AM CDT
ProtoKinetix, Incorporated (OTCQB: PKTX) (the "Company" or "ProtoKinetix"

(www.protokinetix.com) is pleased to announce that ProtoKinetix began trading today on the OTCQB® Venture Marketplace under the symbol "PKTX." The Company was formerly trading on the OTC Pink® marketplace under the same symbol.

CEO Clarence Smith Reports on Edmonton Meetings with Dr. James Shapiro and his Team
BusinessWire - Fri Jun 05, 8:30AM CDT
ProtoKinetix, Incorporated (OTC: PKTX) (the "Company" or "ProtoKinetix"

(www.protokinetix.com) is pleased to announce that CEO Clarence Smith recently returned from visiting Dr. James Shapiro at the University of Alberta. Mr. Smith met with Dr. Shapiro and his impressive team, including Dr. Boris Gala-Lopez. As previously announced, the Company has been heavily involved with the James Shapiro Laboratory for the last 24-months. Dr. Shapiro's team has conducted extensive tests on islet cell transplantation using the AAGP(TM) molecule for the treatment of diabetes using AAGP(TM). Mr. Smith was impressed with the program and gratified that AAGP(TM) was proving to be a central element in the research.

ProtoKinetix Announces Share Issuance
BusinessWire - Wed May 06, 3:53PM CDT
ProtoKinetix, Incorporated (OTC: PKTX) (the "Company" or "Protokinetix"

(www.protokinetix.com) is pleased to announce that it has completed a private placement (the "Offering"

for gross proceeds of $155,000. The Company has issued 1,937,500 shares of common stock at a price of $0.08 per share.

ProtoKinetix Accepts Director's Resignation
BusinessWire - Fri May 01, 10:55AM CDT
ProtoKinetix, Incorporated (OTC: PKTX) (www.protokinetix.com) ("ProtoKinetix" or the "Company"

announces that it has received and accepted the resignation of Mr. Peter K. Jensen as a Director of the Company effective as of April 30, 2015. Mr. Jensen's resignation was due to personal reasons, and not as the result of any disagreement with the Company practices or policies.

ProtoKinetix Announces Acquisition of Patents
BusinessWire - Mon Apr 27, 12:20PM CDT
ProtoKinetix, Incorporated (OTC

KTX) (www.protokinetix.com) ("ProtoKinetix" or the "Company"

is pleased to announce that it has completed the acquisition of a portion of certain patents and all rights associated therewith (the "Patent Rights"

pursuant to the Technology Transfer Agreement entered into with Grant Young on or about April 22, 2015. In exchange for the Patent Rights, Mr. Young will receive $10,000 in cash and a five-year warrant to purchase 6,000,000 shares of the Company's common stock at an exercise price of $0.10 per share.

ProtoKinetix Announces Consulting Agreements
BusinessWire - Fri Apr 03, 1:27PM CDT
ProtoKinetix, Incorporated (OTC: PKTX) (the "Company" or "Protokinetix"

(www.protokinetix.com) is pleased to announce that it has entered into consulting agreements with Clarence E. Smith, President and Chief Executive Officer of the Company, and Susan M. Woodward, Chief Financial Officer of the Company.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Layne's Chicken Fingers Expands with Brownsville Opening

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Employment Law Suit Hits ABC: Alleged Wage Violations

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

D-Wave Quantum Hit with Securities Fraud Lawsuit

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....